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Abstract- Injection drug use has been the most growing rout of drug abuse in Iran in the past decade and it 
has been responsible for the transmission of HIV virus in more than two third of cases. The aim of the present 
study was to determine the prevalence of HIV and hepatitis B in a group of IDU cadavers and to compare the 
results to a group of cadavers of the normal population. In a case-control study the blood samples of the 
cadavers of 400 randomly chosen IDUS and 400 other cadavers as control group were checked for HBS 
antigen and Anti HIV antibody in the forensic medicine center of Tehran. The prevalence of HIV and HBV 
infection was compared in two groups according to their demographic characteristics. The number of HIV 
and HBV positive cadavers was significantly higher in the IDU group than the controls (6.25% vs 0.5%, 
P<0.001, 27.5% vs 3%, P<0.001). The risk of getting infected by HIV virus was 13.27 times greater in the 
IDU group and the risk of HBV infection was 12.26 times greater in this group as compared to the control 
group. The age distribution of IDU cadavers indicated that the percentage of IDU cadavers in the 
reproductive (21-40 years old) age was 80%. The greater prevalence of the HIV and HBV infection especially 
in the reproductive age of IDUS indicates a greater concern to the authorities for more attention to prevention 
and harm reduction programs. 
© 2011 Tehran University of Medical Sciences. All rights reserved. 
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Introduction 
 
As a whole, Iran enjoys the highest per capita of using 
Opium and Heroin in the world: from every 17 Iranian, 
one uses narcotics regularly, and 20 percent of the 
Iranian population of 15-60 year-old are involved in 
using narcotics (1, 2). Historically, in previous decades, 
the prohibition of production and distribution of 
narcotics in the Country gradually caused to develop 
traffic of Heroin in Afghanistan (3). The lower price and 
high presentation of Heroin, caused to increase of the 
number of its takers and finally eruptive growth of the 
number of the addicts of drugs injection in the Country, 
in a way that, in the previous decades, the injection of 
narcotics had been the developing way of using drugs in 
Iran, and up to 2004, more than 300000 addicts of drug 
injection appeared in the country which included 67 
percent of reported new HIV cases since this year (4-6). 
According to the annual report of World Health 
Organization (WHO), up to 2005, 38.6 million people 
were infected by HIV that among this number 4.1 
million people were infected in this year and 2.8 million 
one have died of HIV (7). The recent statistics indicate 
that HIV is developing in Iran, Algeria, Morocco, and 
Libya with more speed (8). The number of infected 
peoples is estimated for more than 30000 (9). It is 
noticeable that unlike most of the regions of the world 
which intravenous injection of drugs enjoys third grade 
in incidence of this disease after sexual infection and 
infection from mother to fetus, in Iran there is a close 
relationship between injection of drugs and HIV 
infection, in a way that based on the report of World 
Health Organization, 67.3 percent of these HIV infected 
patients and 85 percent of HIV affected patients, have 
the prehistory of drugs injection in their pathological 
history (10).  
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Detriments of intravenous injection on personal and 
social health are explicit to everyone. On the other hand, 
hazardous behaviors of this kind of addicts such as using 
joint syringe, using the same syringe again or several 
times, or using infected syringes, are from the main 
factors for infection of AIDS, Hepatitis B and C and 
various lung and cerebral abscesses (11-12), and that 
sexual hazardous behaviors of this infected group will 
cause the infection of these types of diseases in the level 
of families and society. As a whole, various kinds of 
studies in farthest reaches of the and C have a high level 
of infection in addicts of drug injection and their level of 
infection is indicated up to 78 percent for Hepatitis C, 32 
to 70 percent for Hepatitis B and 12 to 30 percent for 
HIV. Some of these studies show that up to 90 percent 
of these people suffer from one of viral diseases and 
there is a direct relationship between the level of cases 
infected by these viruses and duration of drugs 
intravenous injection (13-22). 
Totally Iran was endemic for Hepatitis B and more 
than 35 percent of the population is exposed to this 
disease. 3 percent of the population of Iran was 
indicated as chronic transmitters of this disease in 2000 
(23). The way of transmission of this virus which exists 
in all of the secretions of the body, is mainly through 
sexual relationships, but according to the studies its 
transmission develops all over the world through drugs 
injection by polluted syringe (21). Another important 
issue is the high possibility of being affected 
simultaneously by these viruses, which causes 
considerable increase of death rate, for example in a 
study, the simultaneous affection of HIV and Hepatitis B 
caused to increase of death rate of HIV infected patients 
in a determined period of time, from 6 to 15 (22-24). 
The current study aimed in estimating the rate of 
infection of HIV and Hepatitis B in the bodies of drugs 
injection addicts and determining their sexual and age 
distribution and sexual and age hazardous groups from 
the point of view of infection by these viruses, has been 
planed and performed. 
 
Patients and Methods 
 
In this Case-control study which was performed in 
Forensic Medicine Centre, Tehran, bodies of 400 drugs 
injection addicts and 400 person as control group, were 
studied from point of view of infection with AIDS virus 
and Hepatitis B. The persons who had external 
symptoms in favor of drugs injection and their 
pathological history showed that they had intravenous 
drug injection for minimum 1 month, and in this period 
they had minimum of 7 intravenous drugs injections, 
were studied as drugs injection addicts. On the contrary, 
criteria for selecting control group such as lack of 
physical marks of intravenous drugs abuse and findings 
in favor of intravenous drugs addiction were found in 
their pathological history. As a whole, this group 
included bodies of persons who had died of car 
accidents, sudden death and.  
After selecting bodies, their characteristics were 
collected from police or their families and the 
information were added to the special questionnaires. 
Then, in completely sterilized environment two blood 
samples each for 10 cc, were provided from peripheral 
veins of each body, and in sampling day they were sent 
from Anatomy Hall to the Laboratories on the sampling 
day, in two separate test tubes and in standard testing 
conditions, in cool box and on temperature of 2-5 C, to 
the laboratories of contract parties. Ethical 
considerations were observed for execution of this plan, 
and besides considering cultural values and respect to 
the rights of under studying persons, all of the 
interferences were planned and executed in a way that 
no physical injury and diagnostic interference was made 
on the bodies. 
After centrifugation, the samples which were sent to 
the laboratory were tested for infection with AIDS (Anti 
HIV Ab) and Hepatitis B (HBS Ag) viruses, through 
Eliza Method. 
Results achieved from laboratorial findings, and the 
mentioned information in questionnaires was statically 
analyzed.  
The Chi2 Test was used for analysis. P<0.05 
assumed meaningful and in necessary occasions risk 
chances was estimated by calculation of odds ratio for 
the under-study population. 
 
Results 
 
The results of this study, indicates that the incidence 
of HBS positive cases in drugs injection addicts (27.5 
percent) is considerably more than its incidence in 
control group (3%) (P = 0.0001) and the risk(odds ratio) 
for being infected with Hepatitis B, for drugs injection 
addicts is 12.26 times higher than control group (safe 
distance of 95%: 6.631-22.684). 
HIV incidence in the bodies of drugs injection 
addicts (6.25%) is considerably higher than its incidence 
in control group (0.5%) (P<0.0001) and the risk for 
infection with this virus in drugs injection addicts group 
is 13.27 times higher than control group (safe distance 
of 95%: 3.121-56.397). 
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Age distribution of the bodies of drugs injection 
addicts shows a considerable statistical difference 
comparing with the control group (P ,0.0001), in a way 
that the highest frequency of drugs injection addiction in 
the age group of 20-30 year-old was (46%) and the 
highest frequency of control group in the age group of 
more than 50 years old was (25.25%) (Figure 1). As a 
whole, the age of 20-40 years old, includes 80% of 
drugs injection addicts, whereas this rate is 41.75% in 
control group. However, statistical comparison of the 
number of HIV positives in both age groups was 
impossible because of the insufficient number of these 
cases in control group (2 cases), but comparison of 
infection with Hepatitis B virus shows a considerable 
difference in all of the age groups (Table 1). 
Sex distribution of drugs injection addiction shows a 
considerable difference in both groups (P = 0.0001), and 
the percentage of men in drugs injection addicts group 
(92%) is more than the percentage in control group 
(73.25%) (X2 = 48.177). 
However, the rate of infected cases for both men and 
women in drugs injection addicts is more than witness 
group (Table 2).  
 
 
Figure 1. Frequency distribution of age in drugs injection 
addicts and control groups. 
 
Table 1. Comparsion of the number of HIV and HBV 
positive in both age groups. 
 Age(Year) IV Drug 
abuse 
control P value 
HIV+ <20 5.1% 0% NS 
21-30 6.5% 1.4% NS 
31-40 5.9% 1.1% NS 
>40 7.3% 0% NS 
HBS+ <20 23.1% 1.9% 0.001 
21-30 26.6% 4.1% <0.0001 
31-40 31.6% 4.3% <0.0001 
>40 22% 2.2% <0.0001 
Table 2. Sex distribution and percentage of infected cases in 
two groups. 
 Sex IV Drug 
abuser 
Control P value 
HIV+ Male 6% 0.7% <0.0001 
Female 9.4% 0.0% <0.001 
HBS+ Male 27.4% 3.4% <0.0001 
Female 28.1% 1.9% <0.0001 
 
 
In this case, Jaundice prehistory in drugs injection 
addicts (34.75%) is more than the control group (3.25%) 
(P<0.0001).There is not a statically considerable 
difference between drugs injection addicts and control 
group, from the point of view of transmission blood 
prehistory (P = 0.182). 
It is noteworthy that the rate of tattoo cases in drugs 
injection addicts (59.75%) is much more than witness 
group (7.75%) (P<0.0001). 
 
Discussion 
 
The results of this study indicate the higher incidence of 
Hepatitis B and infection with AIDS virus in drugs 
injection addicts and a much higher risk of infection in 
compare with control group. These results are totally 
parallel to the previous studies and national reports in 
this field (10, 18-22). 
Lesser incidence of infection with AIDS virus in our 
study in compare with most of the foreign studies may 
be different, because of that this virus is new in Iran’s 
society, and that the cases were selected from a special 
geographical district, not from all regions of the country, 
and the laboratorial measuring method. Anyhow, 
regarding to that the policies for decreasing detriments 
in Iran was set into program of policy makers too late in 
compare with other pioneer points of the world (3, 10), 
the possibility for change of infection rate in our 
country, comparing with the other countries in future, 
does not seem unlikely. But fewer infected cases 
promises that in case of performing on-time detriment 
prevention and decreasing measures will cause future 
satisfying results in this case. 
Difference of age distribution of drugs injection 
addicts with control group is so noteworthy, but it is 
warning. As it was mentioned before, about 80 percent 
of drugs injection addicts are in the ages of 20 to 40 
years old or better to say, in fertility ages. It means that 
developing process of drugs injection addiction and 
death rate is highly increasing in the mature group of 
drugs injection addicts’ society. With regard to the 
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development of drugs injection addiction based on 
current statistics and age distribution of drugs injection 
addicts, we can conclude that in case of continuation of 
current process, besides development of these diseases 
through injection, in near future we would meet an ever-
increasing incidence of the disease through sexual 
relationship and the vertical transmission from mother to 
child, and it can be said that after passing several 
generations, the consequences of this process will be 
greatly astonishing.  
According to the UNAIDS report, in this regard, 
AIDS will be the main problem for world health in 2th 
half of 21 century (25). We see a similar process about 
Hepatitis B, that with regard to the higher sexual 
transmission of Hepatitis B against AIDS (30% versus 
0.3%), it is considered that much more people of various 
ages will be exposed to be infected with this disease. 
Youth group, according to this study, is estimated as the 
largest group that is exposed to danger of drugs injection 
addiction and its detriments; such as viral infections, that 
apart from hygienic affairs, a vast spectrum of 
economical, social and judicial consequences will come 
after.  
Yet few numbers of dead addicts in the age group of 
more than 50 years old and its high rate in low ages of 
drugs injection addicts, indicates that survival of this 
group of addicts is highly decreased. Another important 
point is consideration of hazardous behaviors of drugs 
injection addicts. As an example, high statistics of tattoo 
in this group indicates a hazardous behavior in this 
group, which with regard to tattoo in unsanitary 
conditions and its high rate in the society provides the 
possibility of transmission of these diseases to other 
people of the society. 
According to this information, the necessity of 
considering prevention plans firstly and decreasing 
detriments, secondly, in policy-makings and plans of the 
country is inevitable. Vast vaccination or at least 
vaccination of the groups exposed to danger of infection, 
against Hepatitis, educating spouses of drugs injection 
addicts about using particular contraceptives to lessen 
the possibility of transmission of this virus in this way, 
warning to people of the society about sexual and non-
sexual hazardous behaviors such as tattoo, using joint 
personal equipments and observance of occupational 
health in the occasions of contact with the transmitters 
of these viruses, which decreases the possibility of 
hazardous direct or indirect contact with the infection 
sources in the society, should be considered in the plans 
of mass medias and other related organizations.     
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